Help
Subscribe


GastroHep.com - the global online resource for all aspects of gastroenterology, hepatology and endoscopy

 22 January 2018

Advanced search
GastroHep.com - the global online resource for all aspects of gastroenterology, hepatology and endoscopy Profile of Roy Pounder

Home

News  
Journals
Review Articles
Slide Atlas
Video Clips
Online Books
Advanced Digestive Endoscopy
Classical Cases
Conference Diary
PubMed
International GH Links
USA GH Links
National GH Links
National GI Societies
Other Useful Links




Emails on Gastroenterology and Hepatology
the National AIDS Treatment Advocacy Project
Visit the gastroenterology section of the EUMS

News

Routine endoscopic biopsies for H. pylori detection in non-ulcer dyspepsia

In adults with non-ulcer dyspepsia who are undergoing endoscopy, routine biopsy for the detection of H. pylori is costly, but effective, finds a research team in the July issue of Gastrointestinal Endoscopy.

News image

fiogf49gjkf04

The role of endoscopic biopsies in the detection of Helicobacter pylori in patients with non-ulcer dyspepsia is not clear.

In this study, researchers from Canada and Europe assessed the cost-effectiveness of performing routine biopsies to detect H. pylori at upper endoscopy.

The team based their clinical decision-making on outcomes data from published articles and expert opinion.

They evaluated adults (< 45 years) with non-ulcer dyspepsia defined by a normal endoscopy.

Endoscopy with biopsy and rapid urease testing costs $3940 per additional symptom-free patient.
Gastrointestinal Endoscopy

Costs, expressed in Canadian dollars, were tabulated over a 1-year time period.

The main outcome measured by the team was relief of symptoms. This was defined as the absence of symptom persistence or recurrence over the 12 months.

The researchers compared performing a biopsy for the detection of H. pylori with a rapid urease test during gastroscopy, with that of not performing a biopsy.

They also performed a secondary analysis, where they evaluated the cost-effectiveness of obtaining a biopsy specimen for histopathologic evaluation in patients after a negative rapid urease test.

The researchers found that endoscopy with biopsy and rapid urease testing costs $3940 per additional symptom-free patient, compared with endoscopy without biopsy.

However, they determined that this result was sensitive to the difference in symptomatic recurrence rate at 1 year, in patients in whom H. pylori eradication was successful and unsuccessful. The team set this rate at 10%.

Only when the difference in symptomatic recurrence in these patients fell to less than 4% was endoscopy with biopsy over $10,000 per cured patient greater than endoscopy without biopsy.

The team identified little additional benefit associated with histopathologic assessment of biopsy specimens in patients with a negative rapid urease test. Cost per additional cure was $25,529.

Dr Nicholaos Makris's team concluded, "In adults with non-ulcer dyspepsia under age 45 years undergoing endoscopy, routine procurement of a biopsy specimen for detection of H. pylori was more costly yet more effective compared with not obtaining a specimen".

"The cost-effectiveness of a biopsy is dependent on the benefits of H. pylori eradication in this patient population".

"The less likely a patient with non-ulcer dyspepsia is to become asymptomatic after successful H. pylori eradication, the more costly a strategy of routinely obtaining a specimen at endoscopy".

"The additional cost of sending a specimen for histopathologic analysis if the rapid urease test is negative does not appear warranted based on cost-effectiveness considerations".

Gastrointest Endosc 2003; 58: 14-22
04 July 2003

Go to top of page Email this page Email this page to a colleague

 22 January 2018 
Costs of biologic therapies for IBD in the USA
 22 January 2018 
Western vs Asian guidelines for colon cancer management
 22 January 2018 
Improving symptoms in GERD
 19 January 2018 
Ileoanal pouch microbiota
 19 January 2018 
Predicting the risk of early surgery in Crohn’s
 19 January 2018 
Lifestyle intervention vs gastric bypass for obesity and diabetes
 18 January 2018 
Healthcare costs of liver cancer in the USA
 18 January 2018 
High-risk adenomas at colonoscopy
 18 January 2018 
Sleeve gastrectomy vs Roux-en-Y gastric bypass
 17 January 2018 
“Weekend effect” in upper GI hemorrhage
 17 January 2018 
Gut dysbiosis and non-antibiotic prescription medications
 17 January 2018 
Reducing surgical infections in high-outlier colorectal unit
 16 January 2018 
Bundle of care in GI cancer surgery
 16 January 2018 
Anxiety about colonoscopy
 16 January 2018 
Thiopurines and colorectal neoplasia in IBD
 15 January 2018 
Risks of death after liver transplants for liver cancer
 15 January 2018 
Recent advances in hepatocellular carcinoma
 15 January 2018 
Ileostomy output using telemedicine
 12 January 2018 
Surveillance protocols after colorectal cancer resection
 12 January 2018 
Biologic therapy by pregnant women with IBD and infant vaccines
 12 January 2018 
Biologic therapies for IBD in the USA
 11 January 2018 
Genetic risk factors in GERD
 11 January 2018 
Predictor of colorectal adenoma
 11 January 2018 
Ectopic pregnancy in IBD 
 10 January 2018 
Fecal immunochemical tests for colorectal cancer screening
 10 January 2018 
Risk factors for advanced NAFLD
 10 January 2018 
Dyspepsia prevalence with gastroesophageal reflux–type symptoms
 09 January 2018 
Screening intervals for people with family histories of colorectal cancer
 09 January 2018 
Financial impact of colorectal cancer
 09 January 2018 
Current practice and future research in autoimmune hepatitis
 08 January 2018 
Reliability of the IBD index
 08 January 2018 
Improving prognosis in patients with primary sclerosing cholangitis
 08 January 2018 
Aprepitant and nausea with gastroparesis
 05 January 2018 
Autoimmune pancreatitis and IBD
 05 January 2018 
Primary nonresponse to infliximab therapy
 05 January 2018 
Anesthesia assistance in outpatient colonoscopy
 04 January 2018 
Dietary polyphenols in the etiology of IBD
 04 January 2018 
Local esophageal food allergen injections in eosinophilic esophagitis
 04 January 2018 
Yoga vs low-FODMAP in IBS
 03 January 2018 
Population health management for IBD
 03 January 2018 
GERD in asthma and COPD
 03 January 2018 
Critical research gaps in colorectal cancer
 22 December 2017 
Costs of extrahepatic manifestations of Hep C
 22 December 2017 
Cholera vaccine and risk of death in colorectal cancer
 22 December 2017 
Colonoscopy after colorectal cancer resection
 21 December 2017 
Human oral microbiome and pancreatic cancer risk
 21 December 2017 
Health management for IBD
 21 December 2017 
PPI and Alzheimer's disease
 20 December 2017 
Management of abnormal liver blood tests
 20 December 2017 
Incidence of biopsy-verified celiac disease
 20 December 2017 
Osteoporotic fractures in Barrett's esophagus
 19 December 2017 
Alcohol abstinence and alcoholic hepatitis
 19 December 2017 
Family burden of pediatric Crohn's in the USA
 19 December 2017 
Early readmission in IBD patients
 18 December 2017 
Colorectal cancer mortality with low-risk adenomas at colonoscopy
 18 December 2017 
Disease activity indices in celiac disease
 18 December 2017 
Smoking behaviour predicted the risk of surgery in Crohn's
 15 December 2017 
Molecular classification of Crohn's disease
 15 December 2017 
Medical cannabinoid legalization policy and vomiting
 15 December 2017 
Inflammatory diet pattern and colorectal cancer risk

Blackwell Publishing


GastroHep.com is a Blackwell Publishing registered trademark
© 2018 Wiley-Blackwell and GastroHep.com and contributors
Privacy Statement
Disclaimer
About Us